https://www.iconovo.se/wp-content/uploads/2026/01/Breathtaking-innovation_Iconovo-300x92-2026.png
0
0
Eva Norell
https://www.iconovo.se/wp-content/uploads/2026/01/Breathtaking-innovation_Iconovo-300x92-2026.png
Eva Norell2021-05-20 10:15:202021-05-20 10:15:20Iconovo and Respiratorius sign agreement for development of inhalation product to treat COPDLatest news
https://www.iconovo.se/wp-content/uploads/2026/01/Breathtaking-innovation_Iconovo-300x92-2026.png
0
0
Eva Norell
https://www.iconovo.se/wp-content/uploads/2026/01/Breathtaking-innovation_Iconovo-300x92-2026.png
Eva Norell2021-05-20 10:15:202021-05-20 10:15:20Iconovo and Respiratorius sign agreement for development of inhalation product to treat COPD
https://www.iconovo.se/wp-content/uploads/2021/05/Biostock-20210517.jpg
341
640
Eva Norell
https://www.iconovo.se/wp-content/uploads/2026/01/Breathtaking-innovation_Iconovo-300x92-2026.png
Eva Norell2021-05-17 12:11:472021-05-17 12:11:47Iconovo’s CEO on the extended agreement with Amneal
https://www.iconovo.se/wp-content/uploads/2021/05/ICOres_3.jpg
357
827
Eva Norell
https://www.iconovo.se/wp-content/uploads/2026/01/Breathtaking-innovation_Iconovo-300x92-2026.png
Eva Norell2021-05-14 11:14:352021-05-17 09:47:27Iconovo extends agreement with Amneal for generic Symbicort to cover key markets U.S. and China, as well as Nordic sales rightsFollow us on Linkedin
